{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:45:37Z","timestamp":1793727937413,"version":"4.6.1"},"reference-count":210,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1038\/s41581-023-00736-7","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T13:02:39Z","timestamp":1690203759000},"page":"646-657","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Inflammation and gut dysbiosis as drivers of CKD\u2013MBD"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-4321","authenticated-orcid":false,"given":"Pieter","family":"Evenepoel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8785-4820","authenticated-orcid":false,"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Shanahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"736_CR1","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","volume":"74","author":"MJ Sarnak","year":"2019","unstructured":"Sarnak, M. J. et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 74, 1823\u20131838 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"736_CR2","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1681\/ASN.2022010080","volume":"33","author":"HR Yun","year":"2022","unstructured":"Yun, H. R. et al. Coronary artery calcification score and the progression of chronic kidney disease. J. Am. Soc. Nephrol. 33, 1590\u20131601 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"736_CR3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/joim.13459","volume":"291","author":"H Erlandsson","year":"2022","unstructured":"Erlandsson, H. et al. Scoring of medial arterial calcification predicts cardiovascular events and mortality after kidney transplantation. J. Intern. Med. 291, 813\u2013823 (2022).","journal-title":"J. Intern. Med."},{"key":"736_CR4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2011.04.024","volume":"58","author":"MJ Budoff","year":"2011","unstructured":"Budoff, M. J. et al. Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) study. Am. J. Kidney Dis. 58, 519\u2013526 (2011).","journal-title":"Am. J. Kidney Dis."},{"key":"736_CR5","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","volume":"11","author":"SM Moe","year":"2016","unstructured":"Moe, S. M. & Nickolas, T. L. Fractures in patients with CKD: time for action. Clin. J. Am. Soc. Nephrol. 11, 1929\u20131931 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"736_CR6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.kint.2022.04.024","volume":"102","author":"R Shroff","year":"2022","unstructured":"Shroff, R. et al. Naturally occurring stable calcium isotope ratios are a novel biomarker of bone calcium balance in chronic kidney disease. Kidney Int. 102, 613\u2013623 (2022).","journal-title":"Kidney Int."},{"key":"736_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","volume":"36","author":"P Evenepoel","year":"2020","unstructured":"Evenepoel, P. et al. European consensus statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D. Nephrol. Dial. Transpl. 36, 42\u201359 (2020).","journal-title":"Nephrol. Dial. Transpl."},{"key":"736_CR8","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.kint.2018.12.024","volume":"95","author":"P Evenepoel","year":"2019","unstructured":"Evenepoel, P. et al. Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients. Kidney Int. 95, 1461\u20131470 (2019).","journal-title":"Kidney Int."},{"key":"736_CR9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2010121253","volume":"23","author":"HH Malluche","year":"2012","unstructured":"Malluche, H. H., Porter, D. S., Monier-Faugere, M. C., Mawad, H. & Pienkowski, D. Differences in bone quality in low- and high-turnover renal osteodystrophy. J. Am. Soc. Nephrol. 23, 525\u2013532 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"736_CR10","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe, S. et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney int. 69, 1945\u20131953 (2006).","journal-title":"Kidney int."},{"key":"736_CR11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/1873-3468.14313","volume":"596","author":"A Herrlich","year":"2022","unstructured":"Herrlich, A., Kefaloyianni, E. & Rose-John, S. Mechanisms of interorgan crosstalk in health and disease. FEBS Lett. 596, 529\u2013533 (2022).","journal-title":"FEBS Lett."},{"key":"736_CR12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrmicro2974","volume":"11","author":"F Sommer","year":"2013","unstructured":"Sommer, F. & Backhed, F. The gut microbiota \u2014 masters of host development and physiology. Nat. Rev. Microbiol. 11, 227\u2013238 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"736_CR13","doi-asserted-by":"crossref","first-page":"eabp9960","DOI":"10.1126\/science.abp9960","volume":"377","author":"JY Lee","year":"2022","unstructured":"Lee, J. Y., Tsolis, R. M. & Baumler, A. J. The microbiome and gut homeostasis. Science 377, eabp9960 (2022).","journal-title":"Science"},{"key":"736_CR14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41581-019-0172-1","volume":"15","author":"B Meijers","year":"2019","unstructured":"Meijers, B., Evenepoel, P. & Anders, H. J. Intestinal microbiome and fitness in kidney disease. Nat. Rev. Nephrol. 15, 531\u2013545 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"736_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/toxins12060351","volume":"12","author":"L Dai","year":"2020","unstructured":"Dai, L. et al. Sevelamer use in end-stage kidney disease (ESKD) patients associates with poor vitamin K status and high levels of gut-derived uremic toxins: a drug-bug interaction? Toxins 12, 351 (2020).","journal-title":"Toxins"},{"key":"736_CR16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623\u2013628 (2018).","journal-title":"Nature"},{"key":"736_CR17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature18846","volume":"535","author":"JL Sonnenburg","year":"2016","unstructured":"Sonnenburg, J. L. & Backhed, F. Diet\u2013microbiota interactions as moderators of human metabolism. Nature 535, 56\u201364 (2016).","journal-title":"Nature"},{"key":"736_CR18","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/ki.2009.402","volume":"76","author":"P Evenepoel","year":"2009","unstructured":"Evenepoel, P., Meijers, B. K. I., Bammens, B. R. M. & Verbeke, K. Uremic toxins originating from colonic microbial metabolism. Kidney Int. Suppl. 76, S12\u2013S19 (2009).","journal-title":"Kidney Int. Suppl."},{"key":"736_CR19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","volume":"39","author":"J Wong","year":"2014","unstructured":"Wong, J. et al. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am. J. Nephrol. 39, 230\u2013237 (2014).","journal-title":"Am. J. Nephrol."},{"key":"736_CR20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.kint.2017.02.011","volume":"92","author":"E Mishima","year":"2017","unstructured":"Mishima, E. et al. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney int. 92, 634\u2013645 (2017).","journal-title":"Kidney int."},{"key":"736_CR21","volume":"11","author":"B Gao","year":"2021","unstructured":"Gao, B. et al. Butyrate producing microbiota are reduced in chronic kidney diseases. Sci. Rep. 11, 23530 (2021).","journal-title":"Sci. Rep."},{"key":"736_CR22","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027\u20131031 (2006).","journal-title":"Nature"},{"key":"736_CR23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11914-015-0257-0","volume":"13","author":"CM Weaver","year":"2015","unstructured":"Weaver, C. M. Diet, gut microbiome, and bone health. Curr. Osteoporos. Rep. 13, 125\u2013130 (2015).","journal-title":"Curr. Osteoporos. Rep."},{"key":"736_CR24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bone.2019.06.010","volume":"127","author":"JD Guss","year":"2019","unstructured":"Guss, J. D. et al. The microbial metagenome and bone tissue composition in mice with microbiome-induced reductions in bone strength. Bone 127, 146\u2013154 (2019).","journal-title":"Bone"},{"key":"736_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid, Y. & Hand, T. W. Role of the microbiota in immunity and inflammation. Cell 157, 121\u2013141 (2014).","journal-title":"Cell"},{"key":"736_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1882927","volume":"13","author":"F Hosseinkhani","year":"2021","unstructured":"Hosseinkhani, F. et al. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes 13, 1\u201322 (2021).","journal-title":"Gut Microbes"},{"key":"736_CR27","doi-asserted-by":"crossref","first-page":"658354","DOI":"10.3389\/fimmu.2021.658354","volume":"12","author":"N Gasaly","year":"2021","unstructured":"Gasaly, N., de Vos, P. & Hermoso, M. A. Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation. Front. Immunol. 12, 658354 (2021).","journal-title":"Front. Immunol."},{"key":"736_CR28","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/jbmr.2887","volume":"31","author":"CJ Hernandez","year":"2016","unstructured":"Hernandez, C. J., Guss, J. D., Luna, M. & Goldring, S. R. Links between the microbiome and bone. J. Bone Miner. Res. 31, 1638\u20131646 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"736_CR29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/toxins12050285","volume":"12","author":"P Evenepoel","year":"2020","unstructured":"Evenepoel, P., Dejongh, S., Verbeke, K. & Meijers, B. The role of gut dysbiosis in the bone-vascular axis in chronic kidney disease. Toxins 12, 285 (2020).","journal-title":"Toxins"},{"key":"736_CR30","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 14, 576\u2013590 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"736_CR31","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/gerona\/glw240","volume":"72","author":"B Fougere","year":"2017","unstructured":"Fougere, B., Boulanger, E., Nourhashemi, F., Guyonnet, S. & Cesari, M. Chronic inflammation: accelerator of biological aging. J. Gerontol. A Biol. Sci. Med. Sci. 72, 1218\u20131225 (2017).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"736_CR32","doi-asserted-by":"crossref","first-page":"F938","DOI":"10.1152\/ajprenal.00256.2017","volume":"313","author":"JP Kooman","year":"2017","unstructured":"Kooman, J. P. et al. Inflammation and premature aging in advanced chronic kidney disease. Am. J. Physiol. Renal Physiol. 313, F938\u2013F950 (2017).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"736_CR33","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1681\/ASN.2022030378","volume":"33","author":"J Holle","year":"2022","unstructured":"Holle, J. et al. Inflammation in children with chronic kidney disease linked to gut dysbiosis and metabolite imbalance. J. Am. Soc. Nephrol. 33, 2259\u20132275 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"736_CR34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00198-015-3233-8","volume":"27","author":"L Viaene","year":"2016","unstructured":"Viaene, L. et al. Inflammation and the bone-vascular axis in end-stage renal disease. Osteoporos. Int. 27, 489\u2013497 (2016).","journal-title":"Osteoporos. Int."},{"key":"736_CR35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/toxins12040227","volume":"12","author":"T Ebert","year":"2020","unstructured":"Ebert, T. et al. Inflammation and premature ageing in chronic kidney disease. Toxins 12, 227 (2020).","journal-title":"Toxins"},{"key":"736_CR36","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1093\/ndt\/gfz120","volume":"35","author":"P Stenvinkel","year":"2020","unstructured":"Stenvinkel, P., Meyer, C. J., Block, G. A., Chertow, G. M. & Shiels, P. G. Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2-lessons from evolution, the animal kingdom and rare progeroid syndromes. Nephrol. Dial. Transpl. 35, 2036\u20132045 (2020).","journal-title":"Nephrol. Dial. Transpl."},{"key":"736_CR37","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41581-022-00621-9","volume":"18","author":"T Speer","year":"2022","unstructured":"Speer, T., Dimmeler, S., Schunk, S. J., Fliser, D. & Ridker, P. M. Targeting innate immunity-driven inflammation in CKD and cardiovascular disease. Nat. Rev. Nephrol. 18, 762\u2013778 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"736_CR38","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ki.2012.440","volume":"83","author":"HJ Anders","year":"2013","unstructured":"Anders, H. J., Andersen, K. & Stecher, B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 83, 1010\u20131016 (2013).","journal-title":"Kidney Int."},{"key":"736_CR39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfl584","volume":"22","author":"E Schepers","year":"2007","unstructured":"Schepers, E. et al. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol. Dial. Transpl. 22, 592\u2013596 (2007).","journal-title":"Nephrol. Dial. Transpl."},{"key":"736_CR40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.118.034588","volume":"139","author":"T Nakano","year":"2019","unstructured":"Nakano, T. et al. Uremic toxin indoxyl sulfate promotes proinflammatory macrophage activation via the interplay of OATP2B1 and Dll4-notch signaling. Circulation 139, 78\u201396 (2019).","journal-title":"Circulation"},{"key":"736_CR41","volume":"8","author":"F Saaoud","year":"2022","unstructured":"Saaoud, F. et al. Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress-mitochondrial ROS\/glycolysis pathways. JCI Insight 8, e158183 (2022).","journal-title":"JCI Insight"},{"key":"736_CR42","volume":"6","author":"ML Chen","year":"2017","unstructured":"Chen, M. L. et al. Trimethylamine-N-Oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J. Am. Heart Assoc. 6, e006347 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"736_CR43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243\u2013278 (2023).","journal-title":"Cell"},{"key":"736_CR44","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7150\/ijms.48492","volume":"18","author":"W Kamprom","year":"2021","unstructured":"Kamprom, W. et al. P-cresol and indoxyl sulfate impair osteogenic differentiation by triggering mesenchymal stem cell senescence. Int. J. Med. Sci. 18, 744\u2013755 (2021).","journal-title":"Int. J. Med. Sci."},{"key":"736_CR45","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","volume":"25","author":"R Vanholder","year":"2014","unstructured":"Vanholder, R., Schepers, E., Pletinck, A., Nagler, E. V. & Glorieux, G. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J. Am. Soc. Nephrol. 25, 1897\u20131907 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"736_CR46","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ki.2011.445","volume":"81","author":"CY Sun","year":"2012","unstructured":"Sun, C. Y., Chang, S. C. & Wu, M. S. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney int. 81, 640\u2013650 (2012).","journal-title":"Kidney int."},{"key":"736_CR47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12979-020-00200-1","volume":"17","author":"YL Chiu","year":"2020","unstructured":"Chiu, Y. L. et al. Emergence of T cell immunosenescence in diabetic chronic kidney disease. Immun. Ageing 17, 31 (2020).","journal-title":"Immun. Ageing"},{"key":"736_CR48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneph.2013.44","volume":"9","author":"MG Betjes","year":"2013","unstructured":"Betjes, M. G. Immune cell dysfunction and inflammation in end-stage renal disease. Nat. Rev. Nephrol. 9, 255\u2013265 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"736_CR49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-021-03547-7","volume":"594","author":"MJ Yousefzadeh","year":"2021","unstructured":"Yousefzadeh, M. J. et al. An aged immune system drives senescence and ageing of solid organs. Nature 594, 100\u2013105 (2021).","journal-title":"Nature"},{"key":"736_CR50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1874609815666220914104548","volume":"16","author":"R Sharma","year":"2022","unstructured":"Sharma, R. & Diwan, B. A cellular senescence-centric integrated approach to understanding organismal aging. Curr. Aging Sci. 16, 12\u201324 (2022).","journal-title":"Curr. Aging Sci."},{"key":"736_CR51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00424-017-2105-9","volume":"470","author":"F Stumpff","year":"2018","unstructured":"Stumpff, F. A look at the smelly side of physiology: transport of short chain fatty acids. Pflugers Arch. 470, 571\u2013598 (2018).","journal-title":"Pflugers Arch."},{"key":"736_CR52","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3390\/nu10101499","volume":"10","author":"KE Bach Knudsen","year":"2018","unstructured":"Bach Knudsen, K. E. et al. Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients 10, 1499 (2018).","journal-title":"Nutrients"},{"key":"736_CR53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/IJNRD.S200297","volume":"12","author":"ML Terpstra","year":"2019","unstructured":"Terpstra, M. L. et al. Butyrate production in patients with end-stage renal disease. Int. J. Nephrol. Renovasc. Dis. 12, 87\u2013101 (2019).","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"736_CR54","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1042\/CS20190171","volume":"133","author":"S Wang","year":"2019","unstructured":"Wang, S. et al. Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease. Clin. Sci. 133, 1857\u20131870 (2019).","journal-title":"Clin. Sci."},{"key":"736_CR55","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000493862","volume":"48","author":"A Jadoon","year":"2018","unstructured":"Jadoon, A. et al. Gut microbial product predicts cardiovascular risk in chronic kidney disease patients. Am. J. Nephrol. 48, 269\u2013277 (2018).","journal-title":"Am. J. Nephrol."},{"key":"736_CR56","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.34067\/KID.0000292021","volume":"2","author":"O Foresto-Neto","year":"2021","unstructured":"Foresto-Neto, O., Ghirotto, B. & Camara, N. O. S. Renal sensing of bacterial metabolites in the gut-kidney axis. Kidney360 2, 1501\u20131509 (2021).","journal-title":"Kidney360"},{"key":"736_CR57","volume":"9","author":"M Sun","year":"2018","unstructured":"Sun, M. et al. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat. Commun. 9, 3555 (2018).","journal-title":"Nat. Commun."},{"key":"736_CR58","doi-asserted-by":"crossref","first-page":"106062","DOI":"10.1016\/j.intimp.2019.106062","volume":"78","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Inulin alleviates inflammation of alcoholic liver disease via SCFAs-inducing suppression of M1 and facilitation of M2 macrophages in mice. Int. Immunopharmacol. 78, 106062 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"736_CR59","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2019.06.002","volume":"51","author":"A Bachem","year":"2019","unstructured":"Bachem, A. et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T Cells. Immunity 51, 285\u2013297 e285 (2019).","journal-title":"Immunity"},{"key":"736_CR60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000353764","volume":"38","author":"ND Vaziri","year":"2013","unstructured":"Vaziri, N. D., Yuan, J., Nazertehrani, S., Ni, Z. & Liu, S. Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Am. J. Nephrol. 38, 99\u2013103 (2013).","journal-title":"Am. J. Nephrol."},{"key":"736_CR61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/ndt\/gfy238","volume":"34","author":"A Gonzalez","year":"2019","unstructured":"Gonzalez, A. et al. Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression. Nephrol. Dial. Transpl. 34, 783\u2013794 (2019).","journal-title":"Nephrol. Dial. Transpl."},{"key":"736_CR62","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1172\/JCI87430","volume":"126","author":"J Iqbal","year":"2016","unstructured":"Iqbal, J., Yuen, T., Sun, L. & Zaidi, M. From the gut to the strut: where inflammation reigns, bone abstains. J. Clin. Invest. 126, 2045\u20132048 (2016).","journal-title":"J. Clin. Invest."},{"key":"736_CR63","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1172\/JCI86062","volume":"126","author":"JY Li","year":"2016","unstructured":"Li, J. Y. et al. Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J. Clin. Invest. 126, 2049\u20132063 (2016).","journal-title":"J. Clin. Invest."},{"key":"736_CR64","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134092","volume":"5","author":"A Shieh","year":"2020","unstructured":"Shieh, A., Epeldegui, M., Karlamangla, A. S. & Greendale, G. A. Gut permeability, inflammation, and bone density across the menopause transition. JCI Insight 5, e134092 (2020).","journal-title":"JCI Insight"},{"key":"736_CR65","doi-asserted-by":"crossref","first-page":"1938380","DOI":"10.1080\/19490976.2021.1938380","volume":"13","author":"RX Wang","year":"2021","unstructured":"Wang, R. X., Henen, M. A., Lee, J. S., Vogeli, B. & Colgan, S. P. Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor. Gut Microbes 13, 1938380 (2021).","journal-title":"Gut Microbes"},{"key":"736_CR66","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/nep.14064","volume":"27","author":"L Liu","year":"2022","unstructured":"Liu, L., Xu, W., Kong, P. & Dou, Y. The relationships among gut microbiota, hypoxia-inducible factor and anaemia with chronic kidney disease. Nephrology 27, 851\u2013858 (2022).","journal-title":"Nephrology"},{"key":"736_CR67","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly, C. J. et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17, 662\u2013671 (2015).","journal-title":"Cell Host Microbe"},{"key":"736_CR68","doi-asserted-by":"crossref","first-page":"G1138","DOI":"10.1152\/ajpgi.00411.2015","volume":"310","author":"R Schilderink","year":"2016","unstructured":"Schilderink, R. et al. The SCFA butyrate stimulates the epithelial production of retinoic acid via inhibition of epithelial HDAC. Am. J. Physiol. Gastrointest. Liver Physiol. 310, G1138\u2013G1146 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"736_CR69","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang, P. V., Hao, L., Offermanns, S. & Medzhitov, R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl Acad. Sci. USA 111, 2247\u20132252 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"736_CR70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1681\/ASN.2015111285","volume":"28","author":"K Andersen","year":"2017","unstructured":"Andersen, K. et al. Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation. J. Am. Soc. Nephrol. 28, 76\u201383 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"736_CR71","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2215\/CJN.03100315","volume":"10","author":"R Poesen","year":"2015","unstructured":"Poesen, R. et al. Associations of soluble CD14 and endotoxin with mortality, cardiovascular disease, and progression of kidney disease among patients with CKD. Clin. J. Am. Soc. Nephrol. 10, 1525\u20131533 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"736_CR72","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1681\/ASN.2021060843","volume":"33","author":"HT Linh","year":"2022","unstructured":"Linh, H. T. et al. Intestinal bacterial translocation contributes to diabetic kidney disease. J. Am. Soc. Nephrol. 33, 1105\u20131119 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"736_CR73","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10620-014-3202-7","volume":"59","author":"K Shi","year":"2014","unstructured":"Shi, K. et al. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Dig. Dis. Sci. 59, 2109\u20132117 (2014).","journal-title":"Dig. Dis. Sci."},{"key":"736_CR74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-66653-2_8","volume":"1033","author":"ND Rios-Arce","year":"2017","unstructured":"Rios-Arce, N. D. et al. Epithelial barrier function in gut-bone signaling. Adv. Exp. Med. Biol. 1033, 151\u2013183 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"736_CR75","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11914-022-00745-8","volume":"20","author":"R Aurora","year":"2022","unstructured":"Aurora, R. & Veis, D. Does aging activate T-cells to reduce bone mass and quality? Curr. Osteoporos. Rep. 20, 326\u2013333 (2022).","journal-title":"Curr. Osteoporos. Rep."},{"key":"736_CR76","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11926-012-0252-8","volume":"14","author":"IE Bultink","year":"2012","unstructured":"Bultink, I. E., Vis, M., van der Horst-Bruinsma, I. E. & Lems, W. F. Inflammatory rheumatic disorders and bone. Curr. Rheumatol. Rep. 14, 224\u2013230 (2012).","journal-title":"Curr. Rheumatol. Rep."},{"key":"736_CR77","doi-asserted-by":"crossref","first-page":"116468","DOI":"10.1016\/j.bone.2022.116468","volume":"162","author":"D Andreev","year":"2022","unstructured":"Andreev, D., Kachler, K., Schett, G. & Bozec, A. Rheumatoid arthritis and osteoimmunology: the adverse impact of a deregulated immune system on bone metabolism. Bone 162, 116468 (2022).","journal-title":"Bone"},{"key":"736_CR78","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/gutjnl-2014-306947","volume":"64","author":"T Ciucci","year":"2015","unstructured":"Ciucci, T. et al. Bone marrow Th17 TNF\u03b1 cells induce osteoclast differentiation, and link bone destruction to IBD. Gut 64, 1072\u20131081 (2015).","journal-title":"Gut"},{"key":"736_CR79","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.immuni.2018.10.013","volume":"49","author":"AM Tyagi","year":"2018","unstructured":"Tyagi, A. M. et al. The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression. Immunity 49, 1116\u20131131 (2018).","journal-title":"Immunity"},{"key":"736_CR80","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1172\/JCI128521","volume":"129","author":"MM Zaiss","year":"2019","unstructured":"Zaiss, M. M., Jones, R. M., Schett, G. & Pacifici, R. The gut-bone axis: how bacterial metabolites bridge the distance. J. Clin. Invest. 129, 3018\u20133028 (2019).","journal-title":"J. Clin. Invest."},{"key":"736_CR81","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","volume":"97","author":"K Okamoto","year":"2017","unstructured":"Okamoto, K. et al. Osteoimmunology: the conceptual framework unifying the immune and skeletal systems. Physiol. Rev. 97, 1295\u20131349 (2017).","journal-title":"Physiol. Rev."},{"key":"736_CR82","doi-asserted-by":"crossref","first-page":"962969","DOI":"10.3389\/fmed.2022.962969","volume":"9","author":"R Sakthiswary","year":"2022","unstructured":"Sakthiswary, R., Uma Veshaaliini, R., Chin, K. Y., Das, S. & Sirasanagandla, S. R. Pathomechanisms of bone loss in rheumatoid arthritis. Front. Med. 9, 962969 (2022).","journal-title":"Front. Med."},{"key":"736_CR83","doi-asserted-by":"crossref","first-page":"102702","DOI":"10.1016\/j.bcmd.2022.102702","volume":"98","author":"H Bhadricha","year":"2023","unstructured":"Bhadricha, H., Patel, V., Patil, A., Surve, S. & Desai, M. Characterization of peripheral T helper 17 (Th17) cells phenotype in postmenopausal women with estrogen insufficiency. Blood Cell Mol. Dis. 98, 102702 (2023).","journal-title":"Blood Cell Mol. Dis."},{"key":"736_CR84","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ndt\/gfx222","volume":"33","author":"C Cafiero","year":"2018","unstructured":"Cafiero, C. et al. Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems. Nephrol. Dial. Transpl. 33, 65\u201375 (2018).","journal-title":"Nephrol. Dial. Transpl."},{"key":"736_CR85","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm1096-1132","volume":"2","author":"DE Hughes","year":"1996","unstructured":"Hughes, D. E. et al. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-\u03b2. Nat. Med. 2, 1132\u20131136 (1996).","journal-title":"Nat. Med."},{"key":"736_CR86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00223-013-9774-y","volume":"94","author":"T Bellido","year":"2014","unstructured":"Bellido, T. Osteocyte-driven bone remodeling. Calcif. Tissue Int. 94, 25\u201334 (2014).","journal-title":"Calcif. Tissue Int."},{"key":"736_CR87","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","volume":"116","author":"MN Weitzmann","year":"2006","unstructured":"Weitzmann, M. N. & Pacifici, R. Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Invest. 116, 1186\u20131194 (2006).","journal-title":"J. Clin. Invest."},{"key":"736_CR88","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","volume":"130","author":"T Nakamura","year":"2007","unstructured":"Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor \u03b1 and induction of Fas ligand in osteoclasts. Cell 130, 811\u2013823 (2007).","journal-title":"Cell"},{"key":"736_CR89","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jbmr.1500","volume":"27","author":"R Pacifici","year":"2012","unstructured":"Pacifici, R. Role of T cells in ovariectomy induced bone loss-revisited. J. Bone Min. Res. 27, 231\u2013239 (2012).","journal-title":"J. Bone Min. Res."},{"key":"736_CR90","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","volume":"106","author":"S Cenci","year":"2000","unstructured":"Cenci, S. et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-\u03b1. J. Clin. Invest. 106, 1229\u20131237 (2000).","journal-title":"J. Clin. Invest."},{"key":"736_CR91","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmet.2015.09.012","volume":"22","author":"JY Li","year":"2015","unstructured":"Li, J. Y. et al. IL-17A is increased in humans with primary hyperparathyroidism and mediates PTH-induced bone loss in mice. Cell Metab. 22, 799\u2013810 (2015).","journal-title":"Cell Metab."},{"key":"736_CR92","doi-asserted-by":"crossref","first-page":"R126","DOI":"10.1186\/ar3431","volume":"13","author":"DY Chen","year":"2011","unstructured":"Chen, D. Y. et al. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-\u03b1 therapy. Arthritis Res. Ther. 13, R126 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"736_CR93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-12-394299-9.00002-3","volume":"115","author":"N Komatsu","year":"2012","unstructured":"Komatsu, N. & Takayanagi, H. Autoimmune arthritis: the interface between the immune system and joints. Adv. Immunol. 115, 45\u201371 (2012).","journal-title":"Adv. Immunol."},{"key":"736_CR94","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2936","volume":"12","author":"IE Adamopoulos","year":"2010","unstructured":"Adamopoulos, I. E. et al. Interleukin-17A upregulates receptor activator of NF-\u03baB on osteoclast precursors. Arthritis Res. Ther. 12, R29 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"736_CR95","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.archoralbio.2014.05.009","volume":"59","author":"YG Kim","year":"2014","unstructured":"Kim, Y. G. et al. IL-17 inhibits osteoblast differentiation and bone regeneration in rat. Arch. Oral. Biol. 59, 897\u2013905 (2014).","journal-title":"Arch. Oral. Biol."},{"key":"736_CR96","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","volume":"111","author":"G Eghbali-Fatourechi","year":"2003","unstructured":"Eghbali-Fatourechi, G. et al. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111, 1221\u20131230 (2003).","journal-title":"J. Clin. Invest."},{"key":"736_CR97","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bone.2008.02.017","volume":"43","author":"P D\u2019Amelio","year":"2008","unstructured":"D\u2019Amelio, P. et al. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone 43, 92\u2013100 (2008).","journal-title":"Bone"},{"key":"736_CR98","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/09513590.2014.975683","volume":"31","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Changes of serum cytokines-related Th1\/Th2\/Th17 concentration in patients with postmenopausal osteoporosis. Gynecol. Endocrinol. 31, 183\u2013190 (2014).","journal-title":"Gynecol. Endocrinol."},{"key":"736_CR99","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485\u2013498 (2009).","journal-title":"Cell"},{"key":"736_CR100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","volume":"163","author":"K Atarashi","year":"2015","unstructured":"Atarashi, K. et al. Th17 cell induction by adhesion microbes to intestinal epithelial cells. Cell 163, 367\u2013380 (2015).","journal-title":"Cell"},{"key":"736_CR101","first-page":"E8141","volume":"113","author":"TG Tan","year":"2016","unstructured":"Tan, T. G. et al. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc. Natl Acad. Sci. USA 113, E8141\u2013E8150 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"736_CR102","volume":"131","author":"M Yu","year":"2021","unstructured":"Yu, M. et al. Ovariectomy induces bone loss via microbial-dependent trafficking of intestinal TNF+ T cells and Th17 cells. J. Clin. Invest. 131, e143137 (2021).","journal-title":"J. Clin. Invest."},{"key":"736_CR103","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","volume":"90","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel, P., Bover, J. & Urena, T. P. Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int. 90, 1184\u20131190 (2016).","journal-title":"Kidney Int."},{"key":"736_CR104","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cmet.2008.07.001","volume":"8","author":"Y Gao","year":"2008","unstructured":"Gao, Y. et al. T cells potentiate PTH-induced cortical bone loss through CD40L signaling. Cell Metab. 8, 132\u2013145 (2008).","journal-title":"Cell Metab."},{"key":"736_CR105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cmet.2009.07.010","volume":"10","author":"M Terauchi","year":"2009","unstructured":"Terauchi, M. et al. T lymphocytes amplify the anabolic activity of parathyroid hormone through Wnt10b signaling. Cell Metab. 10, 229\u2013240 (2009).","journal-title":"Cell Metab."},{"key":"736_CR106","doi-asserted-by":"crossref","first-page":"E725","DOI":"10.1073\/pnas.1120735109","volume":"109","author":"B Bedi","year":"2012","unstructured":"Bedi, B. et al. Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH. Proc. Natl Acad. Sci. USA 109, E725\u2013E733 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"736_CR107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jbmr.2044","volume":"29","author":"JY Li","year":"2014","unstructured":"Li, J. Y. et al. The sclerostin-independent bone anabolic activity of intermittent PTH treatment is mediated by T-cell-produced Wnt10b. J. Bone Miner. Res. 29, 43\u201354 (2014).","journal-title":"J. Bone Miner. Res."},{"key":"736_CR108","volume":"11","author":"M Yu","year":"2020","unstructured":"Yu, M. et al. PTH induces bone loss via microbial-dependent expansion of intestinal TNF+ T cells and Th17 cells. Nat. Commun. 11, 468 (2020).","journal-title":"Nat. Commun."},{"key":"736_CR109","doi-asserted-by":"crossref","first-page":"156","DOI":"10.15252\/embr.201744421","volume":"19","author":"M Yu","year":"2018","unstructured":"Yu, M. et al. Regulatory T cells are expanded by teriparatide treatment in humans and mediate intermittent PTH-induced bone anabolism in mice. EMBO Rep. 19, 156\u2013171 (2018).","journal-title":"EMBO Rep."},{"key":"736_CR110","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI133473","volume":"130","author":"JY Li","year":"2020","unstructured":"Li, J. Y. et al. Microbiota dependent production of butyrate is required for the bone anabolic activity of PTH. J. Clin. Invest. 130, 1767\u20131781 (2020).","journal-title":"J. Clin. Invest."},{"key":"736_CR111","first-page":"349","volume":"34","author":"JY Li","year":"2018","unstructured":"Li, J. Y. et al. IL-17 receptor signaling in osteoblasts\/osteocytes mediates PTH-induced bone loss and enhances osteocytic RANKL production. J. Bone Min. Res. 34, 349\u2013360 (2018).","journal-title":"J. Bone Min. Res."},{"key":"736_CR112","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.it.2015.10.005","volume":"36","author":"A Baeyens","year":"2015","unstructured":"Baeyens, A., Fang, V., Chen, C. & Schwab, S. R. Exit strategies: s1p signaling and T cell migration. Trends Immunol. 36, 778\u2013787 (2015).","journal-title":"Trends Immunol."},{"key":"736_CR113","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez, E. V. et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639\u2013646 (2007).","journal-title":"Nat. Immunol."},{"key":"736_CR114","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1359-6101(03)00049-2","volume":"14","author":"E Schutyser","year":"2003","unstructured":"Schutyser, E., Struyf, S. & Van Damme, J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor. Rev. 14, 409\u2013426 (2003).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"736_CR115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/toxins14030221","volume":"14","author":"R Vanholder","year":"2022","unstructured":"Vanholder, R., Nigam, S. K., Burtey, S. & Glorieux, G. What if not all metabolites from the uremic toxin generating pathways are toxic? A hypothesis. Toxins 14, 221 (2022).","journal-title":"Toxins"},{"key":"736_CR116","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154888","volume":"132","author":"S Khosla","year":"2022","unstructured":"Khosla, S., Farr, J. N. & Monroe, D. G. Cellular senescence and the skeleton: pathophysiology and therapeutic implications. J. Clin. Invest. 132, e154888 (2022).","journal-title":"J. Clin. Invest."},{"key":"736_CR117","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2013.07.002","volume":"56","author":"H Tanaka","year":"2013","unstructured":"Tanaka, H. et al. p-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways. Bone 56, 347\u2013354 (2013).","journal-title":"Bone"},{"key":"736_CR118","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.21037\/atm-20-5307","volume":"8","author":"H Lin","year":"2020","unstructured":"Lin, H. et al. The role of gut microbiota metabolite trimethylamine N-oxide in functional impairment of bone marrow mesenchymal stem cells in osteoporosis disease. Ann. Transl. Med. 8, 1009 (2020).","journal-title":"Ann. Transl. Med."},{"key":"736_CR119","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.3390\/nu14193955","volume":"14","author":"N Wang","year":"2022","unstructured":"Wang, N., Hao, Y. & Fu, L. Trimethylamine-N-Oxide promotes osteoclast differentiation and bone loss via activating ROS-dependent NF-\u03baB signaling pathway. Nutrients 14, 3955 (2022).","journal-title":"Nutrients"},{"key":"736_CR120","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/2211-5463.12258","volume":"7","author":"K Watanabe","year":"2017","unstructured":"Watanabe, K. et al. Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption. FEBS Open Bio. 7, 1178\u20131185 (2017).","journal-title":"FEBS Open Bio."},{"key":"736_CR121","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","volume":"71","author":"T Nii-Kono","year":"2007","unstructured":"Nii-Kono, T. et al. Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney Int. 71, 738\u2013743 (2007).","journal-title":"Kidney Int."},{"key":"736_CR122","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cca.2018.05.057","volume":"484","author":"WC Liu","year":"2018","unstructured":"Liu, W. C. et al. Effect of uremic toxin-indoxyl sulfate on the skeletal system. Clin. Chim. Acta 484, 197\u2013206 (2018).","journal-title":"Clin. Chim. Acta"},{"key":"736_CR123","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2008.11.007","volume":"20","author":"J Xu","year":"2009","unstructured":"Xu, J. et al. NF-\u03baB modulators in osteolytic bone diseases. Cytokine Growth Factor. Rev. 20, 7\u201317 (2009).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"736_CR124","doi-asserted-by":"crossref","first-page":"10633","DOI":"10.18632\/aging.103283","volume":"12","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Gut microbiota-dependent Trimethylamine N-Oxide are related with hip fracture in postmenopausal women: a matched case-control study. Aging 12, 10633\u201310641 (2020).","journal-title":"Aging"},{"key":"736_CR125","volume":"9","author":"S Lucas","year":"2018","unstructured":"Lucas, S. et al. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat. Commun. 9, 55 (2018).","journal-title":"Nat. Commun."},{"key":"736_CR126","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbrc.2007.02.057","volume":"355","author":"TH Chen","year":"2007","unstructured":"Chen, T. H., Chen, W. M., Hsu, K. H., Kuo, C. D. & Hung, S. C. Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells. Biochem. Biophys. Res. Commun. 355, 913\u2013918 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"736_CR127","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.archoralbio.2008.02.016","volume":"53","author":"T Katono","year":"2008","unstructured":"Katono, T. et al. Sodium butyrate stimulates mineralized nodule formation and osteoprotegerin expression by human osteoblasts. Arch. Oral. Biol. 53, 903\u2013909 (2008).","journal-title":"Arch. Oral. Biol."},{"key":"736_CR128","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1359\/JBMR.050813","volume":"20","author":"TM Schroeder","year":"2005","unstructured":"Schroeder, T. M. & Westendorf, J. J. Histone deacetylase inhibitors promote osteoblast maturation. J. Bone Miner. Res. 20, 2254\u20132263 (2005).","journal-title":"J. Bone Miner. Res."},{"key":"736_CR129","volume":"7","author":"W Lin","year":"2017","unstructured":"Lin, W. et al. Klotho preservation via histone deacetylase inhibition attenuates chronic kidney disease-associated bone injury in mice. Sci. Rep. 7, 46195 (2017).","journal-title":"Sci. Rep."},{"key":"736_CR130","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","volume":"118","author":"RC Shroff","year":"2008","unstructured":"Shroff, R. C. et al. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 118, 1748\u20131757 (2008).","journal-title":"Circulation"},{"key":"736_CR131","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"R Foley","year":"1998","unstructured":"Foley, R., Parfrey, P. & Sarnak, M. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32, S112\u2013S119 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"736_CR132","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneph.2013.176","volume":"9","author":"CM Shanahan","year":"2013","unstructured":"Shanahan, C. M. Mechanisms of vascular calcification in CKD-evidence for premature ageing? Nat. Rev. Nephrol. 9, 661\u2013670 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"736_CR133","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2011.26","volume":"79","author":"O Kuro","year":"2011","unstructured":"Kuro, O. Phosphate and Klotho. Kidney Int. Suppl. 79, S20\u2013S23 (2011).","journal-title":"Kidney Int. Suppl."},{"key":"736_CR134","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.kint.2018.12.014","volume":"95","author":"P Sanchis","year":"2019","unstructured":"Sanchis, P. et al. Arterial \u201cinflammaging\u201d drives vascular calcification in children on dialysis. Kidney Int. 95, 958\u2013972 (2019).","journal-title":"Kidney Int."},{"key":"736_CR135","doi-asserted-by":"crossref","first-page":"494","DOI":"10.18632\/aging.101173","volume":"9","author":"P Stenvinkel","year":"2017","unstructured":"Stenvinkel, P. et al. CDKN2A\/p16INK4a expression is associated with vascular progeria in chronic kidney disease. Aging 9, 494\u2013507 (2017).","journal-title":"Aging"},{"key":"736_CR136","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/cvr\/cvy010","volume":"114","author":"AL Durham","year":"2018","unstructured":"Durham, A. L., Speer, M. Y., Scatena, M., Giachelli, C. M. & Shanahan, C. M. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc. Res. 114, 590\u2013600 (2018).","journal-title":"Cardiovasc. Res."},{"key":"736_CR137","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1161\/ATVBAHA.120.313792","volume":"40","author":"M Duer","year":"2020","unstructured":"Duer, M., Cobb, A. M. & Shanahan, C. M. DNA damage response: a molecular lynchpin in the pathobiology of arteriosclerotic calcification. Arterioscler. Thromb. Vasc. Biol. 40, e193\u2013e202 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"736_CR138","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","volume":"31","author":"G Block","year":"1998","unstructured":"Block, G., Hulbert-Shearon, T., Levin, N. W. & Port, F. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am. J. Kidney Dis. 31, 607\u2013617 (1998).","journal-title":"Am. J. Kidney Dis."},{"key":"736_CR139","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/ATVBAHA.110.216739","volume":"31","author":"A Takemura","year":"2011","unstructured":"Takemura, A. et al. Sirtuin 1 retards hyperphosphatemia-induced calcification of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 31, 2054\u20132062 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"736_CR140","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/CIRCRESAHA.108.181305","volume":"103","author":"AE Ewence","year":"2008","unstructured":"Ewence, A. E. et al. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization. Circ. Res. 103, e28\u2013e34 (2008).","journal-title":"Circ. Res."},{"key":"736_CR141","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/01.RES.0000171451.88616.c2","volume":"96","author":"I Nadra","year":"2005","unstructured":"Nadra, I. et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ. Res. 96, 1248\u20131256 (2005).","journal-title":"Circ. Res."},{"key":"736_CR142","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1074\/jbc.M210868200","volume":"278","author":"A Heiss","year":"2003","unstructured":"Heiss, A. et al. Structural basis of calcification inhibition by \u03b1 2-HS glycoprotein\/fetuin-A. Formation of colloidal calciprotein particles. J. Biol. Chem. 278, 13333\u201313341 (2003).","journal-title":"J. Biol. Chem."},{"key":"736_CR143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228503","volume":"15","author":"M Herrmann","year":"2020","unstructured":"Herrmann, M. et al. Lumenal calcification and microvasculopathy in fetuin-A-deficient mice lead to multiple organ morbidity. PLoS One 15, e0228503 (2020).","journal-title":"PLoS One"},{"key":"736_CR144","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2020.03.016","volume":"303","author":"Y Gatate","year":"2020","unstructured":"Gatate, Y. et al. Mid-term predictive value of calciprotein particles in maintenance hemodialysis patients based on a gel-filtration assay. Atherosclerosis 303, 46\u201352 (2020).","journal-title":"Atherosclerosis"},{"key":"736_CR145","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1681\/ASN.2012030240","volume":"23","author":"A Pasch","year":"2012","unstructured":"Pasch, A. et al. Nanoparticle-based test measures overall propensity for calcification in serum. J. Am. Soc. Nephrol. 23, 1744\u20131752 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"736_CR146","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26166-2","volume":"12","author":"H Mukai","year":"2022","unstructured":"Mukai, H. et al. The effects for inflammatory responses by CPP with different colloidal properties in hemodialysis patients. Sci. Rep. 12, 21856 (2022).","journal-title":"Sci. Rep."},{"key":"736_CR147","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ekir.2020.06.014","volume":"5","author":"ER Smith","year":"2020","unstructured":"Smith, E. R., Pan, F. F. M., Hewitson, T. D., Toussaint, N. D. & Holt, S. G. Effect of sevelamer on calciprotein particles in hemodialysis patients: the sevelamer versus calcium to reduce fetuin-a-containing calciprotein particles in dialysis (SCaRF) randomized controlled trial. Kidney Int. Rep. 5, 1432\u20131447 (2020).","journal-title":"Kidney Int. Rep."},{"key":"736_CR148","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/ndt\/gfac271","volume":"38","author":"U Thiem","year":"2022","unstructured":"Thiem, U. et al. Effect of the phosphate binder sucroferric oxyhydroxide in dialysis patients on endogenous calciprotein particles, inflammation, and vascular cells. Nephrol. Dial. Transpl. 38, 1282\u20131296 (2022).","journal-title":"Nephrol. Dial. Transpl."},{"key":"736_CR149","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ndt\/gfz190","volume":"35","author":"AD Ter Braake","year":"2020","unstructured":"Ter Braake, A. D. et al. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification. Nephrol. Dial. Transpl. 35, 765\u2013773 (2020).","journal-title":"Nephrol. Dial. Transpl."},{"key":"736_CR150","doi-asserted-by":"crossref","first-page":"14941","DOI":"10.3390\/ijms232314941","volume":"23","author":"D Shishkova","year":"2022","unstructured":"Shishkova, D. et al. Calciprotein particles cause physiologically significant pro-inflammatory response in endothelial cells and systemic circulation. Int. J. Mol. Sci. 23, 14941 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"736_CR151","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1042\/CS20201453","volume":"135","author":"OM Kuro","year":"2021","unstructured":"Kuro, O. M. Klotho and calciprotein particles as therapeutic targets against accelerated ageing. Clin. Sci. 135, 1915\u20131927 (2021).","journal-title":"Clin. Sci."},{"key":"736_CR152","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2016.05.044","volume":"251","author":"P Aghagolzadeh","year":"2016","unstructured":"Aghagolzadeh, P. et al. Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-alpha. Atherosclerosis 251, 404\u2013414 (2016).","journal-title":"Atherosclerosis"},{"key":"736_CR153","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/toxins12100624","volume":"12","author":"N Rapp","year":"2020","unstructured":"Rapp, N., Evenepoel, P., Stenvinkel, P. & Schurgers, L. Uremic toxins and vascular calcification-missing the forest for all the trees. Toxins 12, 624 (2020).","journal-title":"Toxins"},{"key":"736_CR154","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/ATVBAHA.119.313414","volume":"40","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Trimethylamine-N-Oxide promotes vascular calcification through activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) inflammasome and NF-\u03baB (Nuclear Factor kappaB) signals. Arterioscler. Thromb. Vasc. Biol. 40, 751\u2013765 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"736_CR155","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1681\/ASN.2018060609","volume":"30","author":"B Opdebeeck","year":"2019","unstructured":"Opdebeeck, B. et al. Indoxyl sulfate and p-Cresyl sulfate promote vascular calcification and associate with glucose intolerance. J. Am. Soc. Nephrol. 30, 751\u2013766 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"736_CR156","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/imr.13134","volume":"312","author":"ME Turner","year":"2022","unstructured":"Turner, M. E., Bartoli-Leonard, F. & Aikawa, E. Small particles with large impact: insights into the unresolved roles of innate immunity in extracellular vesicle-mediated cardiovascular calcification. Immunol. Rev. 312, 20\u201337 (2022).","journal-title":"Immunol. Rev."},{"key":"736_CR157","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/path.5992","volume":"258","author":"Z Lan","year":"2022","unstructured":"Lan, Z. et al. Downregulation of HDAC9 by the ketone metabolite beta-hydroxybutyrate suppresses vascular calcification. J. Pathol. 258, 213\u2013226 (2022).","journal-title":"J. Pathol."},{"key":"736_CR158","doi-asserted-by":"crossref","first-page":"837509","DOI":"10.3389\/fphar.2021.837509","volume":"12","author":"P Amiri","year":"2021","unstructured":"Amiri, P. et al. Role of butyrate, a gut microbiota derived metabolite, in cardiovascular diseases: a comprehensive narrative review. Front. Pharmacol. 12, 837509 (2021).","journal-title":"Front. Pharmacol."},{"key":"736_CR159","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/ATVBAHA.120.315206","volume":"41","author":"AM Cobb","year":"2021","unstructured":"Cobb, A. M. et al. Runx2 (Runt-Related Transcription Factor 2) links the DNA damage response to osteogenic reprogramming and apoptosis of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 41, 1339\u20131357 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"736_CR160","first-page":"e99","volume":"112","author":"Y Liu","year":"2013","unstructured":"Liu, Y., Drozdov, I., Shroff, R., Beltran, L. E. & Shanahan, C. M. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Circ. Res. 112, e99\u2013e109 (2013).","journal-title":"Circ. Res."},{"key":"736_CR161","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cca.2020.02.026","volume":"505","author":"S Arefin","year":"2020","unstructured":"Arefin, S. et al. Nrf2 in early vascular ageing: calcification, senescence and therapy. Clin. Chim. Acta 505, 108\u2013118 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"736_CR162","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.celrep.2019.05.038","volume":"27","author":"KH Muller","year":"2019","unstructured":"Muller, K. H. et al. Poly(ADP-Ribose) links the DNA damage response and biomineralization. Cell Rep. 27, 3124\u20133138.e3113 (2019).","journal-title":"Cell Rep."},{"key":"736_CR163","volume":"11","author":"GL Marques","year":"2021","unstructured":"Marques, G. L. et al. Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3\u20135. Sci. Rep. 11, 2473 (2021).","journal-title":"Sci. Rep."},{"key":"736_CR164","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/HYPERTENSIONAHA.109.134205","volume":"55","author":"JS Shao","year":"2010","unstructured":"Shao, J. S., Cheng, S. L., Sadhu, J. & Towler, D. A. Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension 55, 579\u2013592 (2010).","journal-title":"Hypertension"},{"key":"736_CR165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/path.5193","volume":"247","author":"G Sanchez-Duffhues","year":"2019","unstructured":"Sanchez-Duffhues, G. et al. Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2. J. Pathol. 247, 333\u2013346 (2019).","journal-title":"J. Pathol."},{"key":"736_CR166","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.18632\/aging.102130","volume":"11","author":"LA Henze","year":"2019","unstructured":"Henze, L. A. et al. Impact of C-reactive protein on osteo-\/chondrogenic transdifferentiation and calcification of vascular smooth muscle cells. Aging 11, 5445\u20135462 (2019).","journal-title":"Aging"},{"key":"736_CR167","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbrc.2022.03.051","volume":"604","author":"S Hiramatsu-Asano","year":"2022","unstructured":"Hiramatsu-Asano, S. et al. IL-17A promotes vascular calcification in an ex vivo murine aorta culture. Biochem. Biophys. Res. Commun. 604, 83\u201387 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"736_CR168","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","volume":"361","author":"M Ketteler","year":"2003","unstructured":"Ketteler, M. et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361, 827\u2013833 (2003).","journal-title":"Lancet"},{"key":"736_CR169","doi-asserted-by":"crossref","first-page":"ii31","DOI":"10.1093\/ndt\/gfaa006","volume":"35","author":"L Dai","year":"2020","unstructured":"Dai, L., Schurgers, L. J., Shiels, P. G. & Stenvinkel, P. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage. Nephrol. Dial. Transpl. 35, ii31\u2013ii37 (2020).","journal-title":"Nephrol. Dial. Transpl."},{"key":"736_CR170","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.freeradbiomed.2021.12.010","volume":"178","author":"R Yang","year":"2022","unstructured":"Yang, R. et al. Inhibition of Nrf2 degradation alleviates age-related osteoporosis induced by 1,25-Dihydroxyvitamin D deficiency. Free Radic. Biol. Med. 178, 246\u2013261 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"736_CR171","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1681\/ASN.2021101327","volume":"33","author":"C Xu","year":"2022","unstructured":"Xu, C., Smith, E. R., Tiong, M. K., Ruderman, I. & Toussaint, N. D. Interventions to attenuate vascular calcification progression in chronic kidney disease: a systematic review of clinical trials. J. Am. Soc. Nephrol. 33, 1011\u20131032 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"736_CR172","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41584-022-00764-w","volume":"18","author":"B Soos","year":"2022","unstructured":"Soos, B. et al. Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases. Nat. Rev. Rheumatol. 18, 249\u2013257 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"736_CR173","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1093\/cvr\/cvab231","volume":"117","author":"PM Ridker","year":"2021","unstructured":"Ridker, P. M. From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction? Cardiovasc. Res. 117, e138\u2013e140 (2021).","journal-title":"Cardiovasc. Res."},{"key":"736_CR174","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jbmr.3676","volume":"34","author":"K Iseri","year":"2019","unstructured":"Iseri, K. et al. Effects of denosumab and alendronate on bone health and vascular function in hemodialysis patients: a randomized, controlled trial. J. Bone Miner. Res. 34, 1014\u20131024 (2019).","journal-title":"J. Bone Miner. Res."},{"key":"736_CR175","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ekir.2020.12.002","volume":"6","author":"S Suzuki","year":"2021","unstructured":"Suzuki, S., Suzuki, M., Hanafusa, N., Tsuchiya, K. & Nitta, K. Denosumab recovers aortic arch calcification during long-term hemodialysis. Kidney Int. Rep. 6, 605\u2013612 (2021).","journal-title":"Kidney Int. Rep."},{"key":"736_CR176","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s12350-021-02589-8","volume":"29","author":"JW Bellinge","year":"2022","unstructured":"Bellinge, J. W. et al. The effect of vitamin-K1 and colchicine on vascular calcification activity in subjects with diabetes mellitus (ViKCoVaC): a double-blind 2x2 factorial randomized controlled trial. J. Nucl. Cardiol. 29, 1855\u20131866 (2022).","journal-title":"J. Nucl. Cardiol."},{"key":"736_CR177","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","volume":"23","author":"K Makki","year":"2018","unstructured":"Makki, K., Deehan, E. C., Walter, J. & Backhed, F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe 23, 705\u2013715 (2018).","journal-title":"Cell Host Microbe"},{"key":"736_CR178","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.2012.06553.x","volume":"1258","author":"S Ploger","year":"2012","unstructured":"Ploger, S. et al. Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann. N. Y. Acad. Sci. 1258, 52\u201359 (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"736_CR179","volume":"10","author":"R Singh","year":"2019","unstructured":"Singh, R. et al. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat. Commun. 10, 89 (2019).","journal-title":"Nat. Commun."},{"key":"736_CR180","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.cell.2021.06.019","volume":"184","author":"HC Wastyk","year":"2021","unstructured":"Wastyk, H. C. et al. Gut-microbiota-targeted diets modulate human immune status. Cell 184, 4137\u20134153 (2021).","journal-title":"Cell"},{"key":"736_CR181","doi-asserted-by":"crossref","first-page":"eaaw9255","DOI":"10.1126\/science.aaw9255","volume":"366","author":"JL Sonnenburg","year":"2019","unstructured":"Sonnenburg, J. L. & Sonnenburg, E. D. Vulnerability of the industrialized microbiota. Science 366, eaaw9255 (2019).","journal-title":"Science"},{"key":"736_CR182","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/jn\/136.5.1323","volume":"136","author":"Y Ikeda","year":"2006","unstructured":"Ikeda, Y. et al. Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese population-based osteoporosis (JPOS) study. J. Nutr. 136, 1323\u20131328 (2006).","journal-title":"J. Nutr."},{"key":"736_CR183","volume":"10","author":"MY Tu","year":"2015","unstructured":"Tu, M. Y. et al. Short-term effects of kefir-fermented milk consumption on bone mineral density and bone metabolism in a randomized clinical trial of osteoporotic patients. PLoS One 10, e0144231 (2015).","journal-title":"PLoS One"},{"key":"736_CR184","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature16504","volume":"529","author":"ED Sonnenburg","year":"2016","unstructured":"Sonnenburg, E. D. et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529, 212\u2013215 (2016).","journal-title":"Nature"},{"key":"736_CR185","doi-asserted-by":"crossref","first-page":"E344","DOI":"10.1152\/ajpendo.00366.2021","volume":"322","author":"L Lawenius","year":"2022","unstructured":"Lawenius, L. et al. Development of a synbiotic that protects against ovariectomy-induced trabecular bone loss. Am. J. Physiol. Endocrinol. Metab. 322, E344\u2013E354 (2022).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"736_CR186","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/nep.12272","volume":"19","author":"M Wei","year":"2014","unstructured":"Wei, M. et al. Probiotic Bifidobacterium animalis subsp. lactis Bi-07 alleviates bacterial translocation and ameliorates microinflammation in experimental uraemia. Nephrology 19, 500\u2013506 (2014).","journal-title":"Nephrology"},{"key":"736_CR187","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12020-022-03199-1","volume":"79","author":"L Li","year":"2022","unstructured":"Li, L., Li, A., Gan, L. & Zuo, L. Roxadustat improves renal osteodystrophy by dual regulation of bone remodeling. Endocrine 79, 180\u2013189 (2022).","journal-title":"Endocrine"},{"key":"736_CR188","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ckj\/sfac224","volume":"16","author":"AL Negri","year":"2023","unstructured":"Negri, A. L. Role of prolyl hydroxylase\/HIF-1 signaling in vascular calcification. Clin. Kidney J. 16, 205\u2013209 (2023).","journal-title":"Clin. Kidney J."},{"key":"736_CR189","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15831-7","volume":"11","author":"N Tajik","year":"2020","unstructured":"Tajik, N. et al. Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis. Nat. Commun. 11, 1995 (2020).","journal-title":"Nat. Commun."},{"key":"736_CR190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000515910","volume":"37","author":"F Kuhn","year":"2021","unstructured":"Kuhn, F. et al. Targeting the intestinal barrier to prevent gut-derived inflammation and disease: a role for intestinal alkaline phosphatase. Visc. Med. 37, 383\u2013393 (2021).","journal-title":"Visc. Med."},{"key":"736_CR191","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrd.2017.116","volume":"16","author":"BG Childs","year":"2017","unstructured":"Childs, B. G. et al. Senescent cells: an emerging target for diseases of ageing. Nat. Rev. Drug Discov. 16, 718\u2013735 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"736_CR192","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.tem.2019.07.015","volume":"30","author":"AA Soukas","year":"2019","unstructured":"Soukas, A. A., Hao, H. & Wu, L. Metformin as anti-aging therapy: is it for everyone? Trends Endocrinol. Metab. 30, 745\u2013755 (2019).","journal-title":"Trends Endocrinol. Metab."},{"key":"736_CR193","doi-asserted-by":"crossref","first-page":"121092","DOI":"10.1016\/j.lfs.2022.121092","volume":"312","author":"B Chen","year":"2023","unstructured":"Chen, B. et al. Metformin suppresses oxidative stress induced by high glucose via activation of the Nrf2\/HO-1 signaling pathway in type 2 diabetic osteoporosis. Life Sci. 312, 121092 (2023).","journal-title":"Life Sci."},{"key":"736_CR194","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biochi.2022.08.008","volume":"202","author":"F Malakoti","year":"2022","unstructured":"Malakoti, F. et al. The role of melatonin in bone regeneration: a review of involved signaling pathways. Biochimie 202, 56\u201370 (2022).","journal-title":"Biochimie"},{"key":"736_CR195","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41581-022-00601-z","volume":"18","author":"W Huang","year":"2022","unstructured":"Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L. & Lerman, L. O. Cellular senescence: the good, the bad and the unknown. Nat. Rev. Nephrol. 18, 611\u2013627 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"736_CR196","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","volume":"24","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246\u20131256 (2018).","journal-title":"Nat. Med."},{"key":"736_CR197","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/joim.13141","volume":"288","author":"JL Kirkland","year":"2020","unstructured":"Kirkland, J. L. & Tchkonia, T. Senolytic drugs: from discovery to translation. J. Intern. Med. 288, 518\u2013536 (2020).","journal-title":"J. Intern. Med."},{"key":"736_CR198","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/acel.12458","volume":"15","author":"CM Roos","year":"2016","unstructured":"Roos, C. M. et al. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging Cell 15, 973\u2013977 (2016).","journal-title":"Aging Cell"},{"key":"736_CR199","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/jbmr.3729","volume":"34","author":"JN Farr","year":"2019","unstructured":"Farr, J. N. et al. Independent roles of estrogen deficiency and cellular senescence in the pathogenesis of osteoporosis: evidence in young adult mice and older humans. J. Bone Min. Res. 34, 1407\u20131418 (2019).","journal-title":"J. Bone Min. Res."},{"key":"736_CR200","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr, J. N. et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat. Med. 23, 1072\u20131079 (2017).","journal-title":"Nat. Med."},{"key":"736_CR201","doi-asserted-by":"crossref","first-page":"111565","DOI":"10.1016\/j.mad.2021.111565","volume":"199","author":"ML Doolittle","year":"2021","unstructured":"Doolittle, M. L., Monroe, D. G., Farr, J. N. & Khosla, S. The role of senolytics in osteoporosis and other skeletal pathologies. Mech. Ageing Dev. 199, 111565 (2021).","journal-title":"Mech. Ageing Dev."},{"key":"736_CR202","volume":"8","author":"YH Chan","year":"2019","unstructured":"Chan, Y. H. et al. Cumulative rheumatic inflammation modulates the bone-vascular axis and risk of coronary calcification. J. Am. Heart Assoc. 8, e011540 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"736_CR203","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/rheumatology\/kev198","volume":"54","author":"AN Kiani","year":"2015","unstructured":"Kiani, A. N. et al. Coronary calcification in SLE: comparison with the multi-ethnic study of atherosclerosis. Rheumatology 54, 1976\u20131981 (2015).","journal-title":"Rheumatology"},{"key":"736_CR204","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.ackd.2019.09.006","volume":"26","author":"P Evenepoel","year":"2019","unstructured":"Evenepoel, P., Opdebeeck, B., David, K. & D\u2019Haese, P. C. Bone-vascular axis in chronic kidney disease. Adv. Chronic Kidney Dis. 26, 472\u2013483 (2019).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"736_CR205","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nm0411-430","volume":"17","author":"S Khosla","year":"2011","unstructured":"Khosla, S. The bone and beyond: a shift in calcium. Nat. Med. 17, 430\u2013431 (2011).","journal-title":"Nat. Med."},{"key":"736_CR206","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s10753-020-01357-z","volume":"44","author":"C Yu","year":"2021","unstructured":"Yu, C., Zhang, C., Kuang, Z. & Zheng, Q. The role of NLRP3 inflammasome activities in bone diseases and vascular calcification. Inflammation 44, 434\u2013449 (2021).","journal-title":"Inflammation"},{"key":"736_CR207","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/ndt\/gfl281","volume":"21","author":"P Kotanko","year":"2006","unstructured":"Kotanko, P., Carter, M. & Levin, N. W. Intestinal bacterial microflora \u2014 a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol. Dial. Transpl. 21, 2057\u20132060 (2006).","journal-title":"Nephrol. Dial. Transpl."},{"key":"736_CR208","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrendo.2016.91","volume":"12","author":"MN Weitzmann","year":"2016","unstructured":"Weitzmann, M. N. & Ofotokun, I. Physiological and pathophysiological bone turnover \u2014 role of the immune system. Nat. Rev. Endocrinol. 12, 518\u2013532 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"736_CR209","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bone.2017.04.009","volume":"115","author":"RM Jones","year":"2018","unstructured":"Jones, R. M., Mulle, J. G. & Pacifici, R. Osteomicrobiology: the influence of gut microbiota on bone in health and disease. Bone 115, 59\u201367 (2018).","journal-title":"Bone"},{"key":"736_CR210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41581-020-00345-8","volume":"17","author":"D Mafra","year":"2020","unstructured":"Mafra, D. et al. Food as medicine: targeting the uraemic phenotype in chronic kidney disease. Nat. Rev. Nephrol. 17, 153\u2013171 (2020).","journal-title":"Nat. Rev. Nephrol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00736-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00736-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00736-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:08:14Z","timestamp":1694768894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-023-00736-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":210,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1038\/s41581-023-00736-7","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"19 June 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}